The treatment of inveterate vulvo-vaginal candidosis.
The antifungal treatment of recurrent vulvo-vaginal candidosis is described. Factors which predispose to the condition are discussed and details of their investigation and management mentioned. The problem of reinfection, both from a sexual contact and from the bowel is reviewed, and the general features of management considered.
Bingham
J S
JS
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D001888:Boric Acids / Q000008:administration & dosage / Q000627:therapeutic use; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy* / Q000276:immunology; D002908:Chronic Disease; D003022:Clotrimazole / Q000008:administration & dosage / Q000627:therapeutic use; D003276:Contraceptives, Oral / Q000009:adverse effects; D048909:Diabetes Complications; D005260:Female; D006801:Humans; D008597:Menstrual Cycle; D008825:Miconazole / Q000008:administration & dosage / Q000627:therapeutic use; D009761:Nystatin / Q000008:administration & dosage / Q000627:therapeutic use; D010349:Patient Compliance; D012007:Rectum / Q000382:microbiology; D012725:Sexual Behavior; D013488:Suppositories; D013960:Thyroid Function Tests; D014621:Vagina / Q000382:microbiology
D000305:Adrenal Cortex Hormones; D001888:Boric Acids; D003276:Contraceptives, Oral; D013488:Suppositories; D009761:Nystatin; D008825:Miconazole; D003022:Clotrimazole; C032688:boric acid